Metraipolis › archive › dc_fa156ea491a9

Evaluation of dihydropyranocoumarins as potent inhibitors against triple-negative breast cancer: An integrated of in silico, quantum & molecular modeling… — Europe PMC PMID:41337159

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41337159
DOI: 10.1371/journal.pone.0334939
License (as archived): solo-consultazione
Archived: 2026-11-07T23:27:43.228Z
SHA-256 of the archived text: 1c7f43c70b2b7fb2d643c4b3772f00e986ff839ed421eefe877462e78e2c1a0f
Stable URL of this page: https://metraipolis.com/documento/dc_fa156ea491a9

How to cite

Evaluation of dihydropyranocoumarins as potent inhibitors against triple-negative breast cancer: An integrated of in silico, quantum & molecular modeling… — Europe PMC PMID:41337159 — Europe PMC (en), https://europepmc.org/article/MED/41337159 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa156ea491a9 (Metraipolis archive dc_fa156ea491a9, sha256 1c7f43c70b2b7fb2d643c4b3772f00e986ff839ed421eefe877462e78e2c1a0f)

BibTeX

@misc{dcfa156ea491a9,
  title = {Evaluation of dihydropyranocoumarins as potent inhibitors against triple-negative breast cancer: An integrated of in silico, quantum & molecular modeling… — Europe PMC PMID:41337159},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41337159},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa156ea491a9; sha256 1c7f43c70b2b7fb2d643c4b3772f00e986ff839ed421eefe877462e78e2c1a0f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41337159. Agents can read the archived copy with the MCP tool read_document.